Planned Parenthood announced today that it will no longer sell harvested aborted-baby body parts. Instead, the abortion mill will just give them away. If Planned Parenthood didn’t do anything illegal, as it claimed, why stop selling the parts?
— The Hill (@thehill) October 13, 2015
Abortion mill president Cecile Richards wrote that people who want to protect the voiceless and vulnerable unborn are “extremists,” and our “real goal…has nothing to do with our fetal tissue donation compliance process but is instead to ban abortion in the U.S. and block women from getting any health care from Planned Parenthood. Today, we’re taking their smokescreen away.”
Regardless of what she calls our outrage, the Center for Medical Progress (CMP) served a vital role in bringing these heinous practices to the public’s attention. The next step is to ban donating and harvesting of aborted babies altogether.
Planned Parenthood kills over 300,000 unborn babies a year. This is not health care. Defunding the organization could mean more money for clinics that do provide health care. But the “right” to kill one’s own children is entrenched, and we must press on.
Why, WORLD asked, hasn’t the Obama administration audited Planned Parenthood?
In one of CMP’s undercover videos, abortionist Savita Ginde, vice president and medical director for Planned Parenthood of the Rocky Mountains, tells actors posing as tissue buyers that Planned Parenthood affiliates categorize tissue sales as “research.” The Public Health Service Act requires annual reports from entities supported by the National Institute of Health (NIH) “describing research involving therapeutic transplantation of human fetal tissue.”
In July, The Stream filed a Freedom of Information Act request for documents and emails related to Planned Parenthood and the audits.
The Stream received redacted emails and letters from HHS to Congress stating the NIH hadn’t been involved in any therapeutic fetal tissue transplants. According to the letter, NIH hadn’t provided “any financial support for human fetal tissue transplantation research” since 2007.